Alan Bart Sandler
Equibles does not estimate personal net worth.
About Alan Bart Sandler
The proxy statement of Zai Lab Ltd reports total compensation of $7,329,748 for Alan Bart Sandler in fiscal 2022, including a base salary of $463,602. Disclosed compensation is on record for 3 fiscal years. Revolution Medicines, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Revolution Medicines, Inc. includes Mark Goldsmith (CEO and Board Member), Jack Anders (CFO), Margaret Horn (COO) and 7 others.
Affiliation history
-
Revolution Medicines, Inc. (RVMD)
Source not stated
Current -
Zai Lab Ltd (ZLAB)
Proxy statement
Start not stated–2022-05-02
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Revolution Medicines, Inc.
- Mark Goldsmith CEO, Board Member
- Jack Anders CFO
- Margaret Horn COO
- Jeffrey Cislini General Counsel
- Alexis Borisy Board Member
- Elizabeth McKee Anderson Board Member
- Eric Schmidt Board Member
- Flavia Borellini Board Member
- Frank K. Clyburn Board Member
- Frank K. Clyburn, Jr. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Zai Lab Ltd (ZLAB) | Former President, Head of Global Development, Oncology | $463,602 | $7,329,748 |
| 2021 | Zai Lab Ltd (ZLAB) | Former President, Head of Global Development, Oncology | $540,000 | $6,622,039 |
| 2020 | Zai Lab Ltd (ZLAB) | Former President, Head of Global Development, Oncology | $45,000 | $7,063,890 |
Recent activity
No call appearances or filed executive changes recorded yet.